gene therapy
2025 · 4th Quarter (Oct 1 - Dec 31)
UNIQURE BIOPHARMA B.V.
Filed by TARPLIN, DOWNS & YOUNG, LLC.
Open official filingSource-reported fields
Filing overview
- Type
- Registration
- Posted
- Jan 13, 2026
- Income
- Not reported
- Expenses
- Not reported
- Registrant
- TARPLIN, DOWNS & YOUNG, LLC
- Client
- UNIQURE BIOPHARMA B.V.
- Filing UUID
- 083eb720-582d-4d87-842c-03677406cd59
- Termination date
- Not reported
Literal source text
Lobbying issues and bill citations
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.